Efficacy of octreotide but not long-acting somatostatin analogue for severe refractory diabetic diarrhoea

Diabetic Medicine

Volumn 26, Issue 8, 2009, Pages 828-829

  Corbould, A ^a   Campbell, J ^a  

^a LAUNCESTON GENERAL HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPEPTIN; LANREOTIDE AUTOGEL; OCTREOTIDE; UNCLASSIFIED DRUG;

ADULT; BEDTIME DOSAGE; CASE REPORT; DIARRHEA; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG SAFETY; DRUG SUBSTITUTION; DRUG TOLERABILITY; DRUG WITHDRAWAL; FECES INCONTINENCE; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LETTER; SYMPTOMATOLOGY; TREATMENT RESPONSE;

ADULT; DIABETES MELLITUS, TYPE 1; DIARRHEA; FEMALE; GASTROINTESTINAL AGENTS; HUMANS; OCTREOTIDE; SOMATOSTATIN; TREATMENT OUTCOME;

EID: 68149134445     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2009.02766.x     Document Type: Letter

References (12)

1. Dudi RJ, Anderson DS, Forsythe AB, Zeigler MG, O'Dorisio TM. Treatment of diabetic diarrhea and orthostatic hypotension with somatostatin analogue SMS 201-995. Am J Med 1987 83 : 584 588.
2. Mourad FH, Gorard D, Thillainayagam AV, Colin-Jones D, Farthing MJG. Effective treatment of diabetic diarrhoea with somatostatin analogue, octreotide. Gut 1992 33 : 1578 1580.
3. Walker JJ, Kaplan DS. Efficacy of the somatostatin analog octreotide in the treatment of two patients with refractory diabetic diarrhea. Am J Gastroenterol 1993 88 : 765 767.
4. Nakabayashi H, Fujii S, Miwa U, Seta T, Takeda R. Marked improvement of diabetic diarrhea with the somatostatin analogue octreotide. Arch Intern Med 1994 154 : 1863 1867.
5. Murao S, Hirata K, Ishada T, Takahara J. Severe diabetic diarrhea successfully treated with octreotide, a somatostatin analogue. Endocr J 1999 46 : 477 478.
6. Pop-Busui R, Chey W, Stevens MJ. Severe hypertension induced by the long-acting somatostatin analogue LAR in a patient with diabetic autonomic neuropathy. J Clin Endocrinol Metab 2000 85 : 943 946.
7. Meyer C, O'Neal DN, Connell W, Alford F, Ward G, Jenkins AJ. Octreotide treatment of severe diabetic diarrhoea. Int Med J 2003 33 : 617 618.
8. Farthing MJG. The role of somatostatin analogues in the treatment of refractory diarrhoea. Digestion 1996 57 : 107 113.
9. Rubin J, Ajani J, Schirmer W, Venook AP, Bukowski R, Pommier R et al. Octreotide acetate long-acting formulation versus open-label subcutaneous octreotide acetate in malignant carcinoid syndrome. J Clin Oncol 1999 17 : 600 606.
10. Harris AG. Somatostatin and somatostatin analogues: pharmacokinetics and pharmacodynamic effects. Gut 1994 Suppl. 3 : S1 S4.
11. Astruc B, Marbach P, Bouterfa H, Denot C, Safari M, Vitaliti A et al. Long-acting octreotide and prolonged-release Lanreotide formulations have different pharmacokinetic profiles. J Clin Pharmacol 2005 45 : 836 844.
12. Reubi JC, Schär J-C, Waser B, Wenger S, Heppeler A, Schmitt JS et al. Affinity profiles for human somatostatin receptor subtypes SST1-SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use. Eur J Nucl Med 2000 27 : 273 281.